New Shipping Container Launched for GLP-1 Medications

As demand for GLP-1 therapies grows, new specialized packaging aims to improve the mail-order delivery process.

Updated on Oct. 6, 2026 in Diabetes

Isometric editorial illustration of a cylindrical pharmaceutical shipping canister with a layered insulation cross-section.
Veritiv has launched the TempSafe RxShield, a specialized canister designed to maintain stable temperatures for GLP-1 medications during mail-order shipping. AI Illustration. Upload story photo >

Live Poll

Do you believe the growth of mail-order prescription delivery makes healthcare more accessible for you?

Veritiv Operating Company has introduced the TempSafe RxShield, an insulated canister designed to transport sensitive medications like GLP-1 therapies. This development addresses the needs of a market where over 60% of specialty pharmacy prescriptions are now delivered by mail.

Why it matters

The rapid rise in GLP-1 usage, which jumped from 3% in 2024 to 11% in 2026, has created significant logistics challenges for maintaining temperature-sensitive supplies. This packaging aims to optimize storage and reduce shipping costs as the total market is projected to reach $190 billion by 2035.

The TempSafe RxShield is validated to ISTA 7E thermal performance standards, maintaining necessary refrigerated temperatures for 36 hours. The canister weighs 240 grams and holds four 10 mL vials.

The players

Veritiv Operating Company

A distribution firm that operates over 120 locations and provides packaging solutions for pharmaceutical shipping.

The details

The canister utilizes a cylindrical design with thin, cellulose-based insulation to minimize wasted space while protecting delicate vials. By incorporating a foam buffer and phase change management bottle, the system ensures medications remain stable during transport. These design improvements reduce dimensional weight by 30%, which helps the company manage its distribution across 120 locations.

Timeline

  1. 2024: Adult GLP-1 usage rate was 3 percent.

  2. 2026: Adult GLP-1 usage rate reached 11 percent.

  3. 2035: Projected GLP-1 market value reaches $190 billion.

Health Landscape

This launch follows the established benchmarks for ISTA 7E thermal performance standards in medical cold-chain logistics. It reflects the broader trend of industrial scaling in response to the massive expansion of the GLP-1 pharmaceutical market.

If you receive GLP-1 medications by mail, verify that your pharmacy maintains temperature control during transit. Any concerns about the condition of your medication upon arrival are worth discussing with your doctor or pharmacist.

The takeaway

As mail-order specialty pharmacies become more common, reliable cold-chain packaging is essential for medication efficacy. Always inspect refrigerated shipments for intact cooling materials upon delivery and consult your physician if you suspect your medication was exposed to improper temperatures.

Further reading

For more on medication management, visit Diabetes.

Source note: This article includes information reported by PlasticsToday.

Live Poll

Do you believe the growth of mail-order prescription delivery makes healthcare more accessible for you?